Montgomery Maryland Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: Montgomery
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Montgomery Maryland Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal document outlining the terms and conditions of a licensing agreement between the two parties. The agreement allows Gentling, Inc. to license collateral technology or intellectual property owned by The University of North Texas Health Science Center based in Montgomery, Maryland. This licensing agreement serves as a means for Gentling, Inc. to gain access to valuable research, patents, and scientific discoveries generated by The University of North Texas Health Science Center. By entering into this agreement, Gentling, Inc. can utilize the licensed collateral for commercial purposes, such as developing and marketing innovative products or services in the field of health sciences. The Montgomery Maryland Collateral License Agreement typically encompasses key aspects such as: 1. Scope of the Agreement: This section defines the specific collateral technology or intellectual property being licensed, outlining the rights and limitations of Gentling, Inc. in utilizing it. 2. Exclusivity and Territory: The agreement may specify whether the license granted is exclusive or non-exclusive, granting Gentling, Inc. sole or shared access to the collateral technology within a particular geographic territory, such as Montgomery, Maryland. 3. Term and Renewal: The duration of the license is specified, along with provisions for renewal or termination of the agreement. It may also address any milestones, royalties, or financial obligations tied to the agreement. 4. Intellectual Property Rights: This section outlines the ownership rights of the licensed collateral technology, ensuring that the University retains ownership while granting Gentling, Inc. sufficient rights to use and exploit it within agreed-upon parameters. 5. Confidentiality and Non-Disclosure: Both parties agree to maintain the confidentiality of any proprietary information disclosed during the licensing process and not to disclose it to third parties. 6. Indemnification and Liability: The agreement may detail each party's responsibilities and liabilities in the event of any disputes, claims, or damages arising from the licensed technology's use. Types of Montgomery Maryland Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may include specific agreements for: 1. Patent Licensing: Gentling, Inc. may license patented technologies or inventions owned by The University of North Texas Health Science Center, allowing them to exploit and commercialize the invention, paying royalty fees or other financial considerations. 2. Research Collaboration: Gentling, Inc. may collaborate with The University of North Texas Health Science Center on specific research projects, accessing the collateral intellectual property resulting from the joint efforts for mutual benefit. Overall, the Montgomery Maryland Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center serves as a legal framework to protect the interests of both parties while promoting innovation, research, and commercialization in the field of health sciences within Montgomery, Maryland.

The Montgomery Maryland Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal document outlining the terms and conditions of a licensing agreement between the two parties. The agreement allows Gentling, Inc. to license collateral technology or intellectual property owned by The University of North Texas Health Science Center based in Montgomery, Maryland. This licensing agreement serves as a means for Gentling, Inc. to gain access to valuable research, patents, and scientific discoveries generated by The University of North Texas Health Science Center. By entering into this agreement, Gentling, Inc. can utilize the licensed collateral for commercial purposes, such as developing and marketing innovative products or services in the field of health sciences. The Montgomery Maryland Collateral License Agreement typically encompasses key aspects such as: 1. Scope of the Agreement: This section defines the specific collateral technology or intellectual property being licensed, outlining the rights and limitations of Gentling, Inc. in utilizing it. 2. Exclusivity and Territory: The agreement may specify whether the license granted is exclusive or non-exclusive, granting Gentling, Inc. sole or shared access to the collateral technology within a particular geographic territory, such as Montgomery, Maryland. 3. Term and Renewal: The duration of the license is specified, along with provisions for renewal or termination of the agreement. It may also address any milestones, royalties, or financial obligations tied to the agreement. 4. Intellectual Property Rights: This section outlines the ownership rights of the licensed collateral technology, ensuring that the University retains ownership while granting Gentling, Inc. sufficient rights to use and exploit it within agreed-upon parameters. 5. Confidentiality and Non-Disclosure: Both parties agree to maintain the confidentiality of any proprietary information disclosed during the licensing process and not to disclose it to third parties. 6. Indemnification and Liability: The agreement may detail each party's responsibilities and liabilities in the event of any disputes, claims, or damages arising from the licensed technology's use. Types of Montgomery Maryland Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may include specific agreements for: 1. Patent Licensing: Gentling, Inc. may license patented technologies or inventions owned by The University of North Texas Health Science Center, allowing them to exploit and commercialize the invention, paying royalty fees or other financial considerations. 2. Research Collaboration: Gentling, Inc. may collaborate with The University of North Texas Health Science Center on specific research projects, accessing the collateral intellectual property resulting from the joint efforts for mutual benefit. Overall, the Montgomery Maryland Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center serves as a legal framework to protect the interests of both parties while promoting innovation, research, and commercialization in the field of health sciences within Montgomery, Maryland.